BlackRock Inc. - SAB BIOTHERAPEUTICS INC ownership

SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T103. A total of 28 filers reported holding SAB BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of SAB BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$33,165
-24.1%
52,6430.0%0.00%
Q2 2023$43,694
-9.7%
52,643
-52.1%
0.00%
Q1 2023$48,406
-24.1%
110,013
+1.7%
0.00%
Q4 2022$63,799
-27.5%
108,153
-14.0%
0.00%
Q3 2022$88,000
-52.4%
125,722
-1.4%
0.00%
Q2 2022$185,000
-32.2%
127,446
+75.7%
0.00%
Q1 2022$273,000
-51.2%
72,518
+1.3%
0.00%
Q4 2021$559,00071,6080.00%
Other shareholders
SAB BIOTHERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
First PREMIER Bank 652,440$946,0000.28%
METEORA CAPITAL, LLC 292,538$424,0000.08%
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 78,115$113,0000.02%
SILVER OAK SECURITIES, Inc 51,941$64,0000.01%
Shaolin Capital Management LLC 275,000$399,0000.01%
Elgethun Capital Management 13,296$18,0000.01%
LGL PARTNERS, LLC 23,000$33,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 84,000$122,0000.00%
Spectrum Management Group, LLC 5,030$7,0000.00%
Veritable, L.P. 43,551$63,0000.00%
View complete list of SAB BIOTHERAPEUTICS INC shareholders